Juan C. Jaen - 15 Jun 2024 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role
President
Signature
/s/ Carolyn Tang, Attorney-in-Fact
Issuer symbol
RCUS
Transactions as of
15 Jun 2024
Net transactions value
-$118,264
Form type
4
Filing time
18 Jun 2024, 16:54:17 UTC
Previous filing
28 Feb 2024
Next filing
17 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCUS Common Stock Tax liability $118,264 -6,969 -2% $16.97 334,506 15 Jun 2024 Direct F1
holding RCUS Common Stock 1,188,233 15 Jun 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.